CD19 and non-Hodgkin lymphoma: Turtle Turtle CJ CJ Hanafi Hanafi L-A L-A Berger Berger C C Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells Sci Transl Med Sci Transl Med 2016 2016 8 8 355 355 355ra116 355ra116 10.1126/scitranslmed.aaf8621 10.1126/scitranslmed.aaf8621